PATENT CLAIM ANALYSIS

Application Number: 16110017
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "235800"]

Abstract:
Methods of treating vitiligo using JAK/STAT modulating compounds are provided herein. The JAK/STAT modulating compounds may be selected from 5-((2-((4-fluoro-3-methoxy-5-methylphenyl)amino)-5-methylpyrimidin-4-yl)amino)benzo[d] oxazol-2(3H)-one, disodium (5-((2-((4-fluoro-3-methoxy-5-methylphenyl)amino)-5-methylpyrimidin-4-yl)amino)-2-oxobenzo[d]oxazol-3(2H)-yl)methyl phosphate, tofacitinib, ruxolitinib, baricitinib, lestaurtinib, decernotinib, TG101348, Janex 1, PF-956980, WHI-P154, ZM-39923, NSC114792, cerdulatinib, fedratinib, PF-06263276, CEP-33779, AZD-1480, SHR0302, oclacitinib, filgotinib, gandotinib, momelotinib, pacritinib, upadacitinib, peficitinib, PF-04965842, N-(3-acetamido-5-(quinaxalin-2-yl) phenyl) acrylamide, 1-[(2S,5R)-2-Methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-2-propen-1-one malonate (PF-06651600), [(1S)-2,2-Difluorocyclopropyl][3-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-3,8-diazabicyclo[3.2.1]oct-8-yl]-methanone tosylate, a derivative thereof, or a combination thereof. The JAK/STAT modulating compounds may be formulated for topical or oral delivery.

Claim (Index 6):
The method of  claim 1 , wherein route of administration is selected from the group consisting of oral, topical, systemic, parenteral, subcutaneous, intramuscular, intraperitoneal, transdermal, intravenous, rectal, local, sublingual, buccal, ocular, intravaginal, by inhalation, by depot injection, by implant, and a combination thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 96.0
- Lexical Diversity: 2.04
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13444684', '15875897', '15880385', '13283471', '12030031']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7926321145324481
- 35 USC 102 Novelty (BERT): 0.5141062393157687
- Combined Prediction Score: 0.7647795270107802
- Mean Citation Score: 254.523536
- Max Citation Score: 287.38953
- Similarity Product: 205.852772451936

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test